| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018671470 |
| P356 | DOI | 10.1038/283583A0 |
| P698 | PubMed publication ID | 6928257 |
| P50 | author | Jerome Ritz | Q41590860 |
| P2093 | author name string | S F Schlossman | |
| H Lazarus | |||
| J M Pesando | |||
| J Notis-McConarty | |||
| P2860 | cites work | Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 |
| Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion | Q34345842 | ||
| Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens | Q34686040 | ||
| Separation of functional subsets of human T cells by a monoclonal antibody | Q34686110 | ||
| Cell sorter analysis of leukaemia-associated antigens on human myeloid precursors | Q40577543 | ||
| Monoclonal antibodies against human lymphocyte antigens | Q40902818 | ||
| A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody | Q41047952 | ||
| Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. | Q46302372 | ||
| CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Q52828546 | ||
| Antisera to acute lymphoblastic leukemia cells | Q66894609 | ||
| P433 | issue | 5747 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| antibody | Q79460 | ||
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | 583-585 | |
| P577 | publication date | 1980-02-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | A monoclonal antibody to human acute lymphoblastic leukaemia antigen | |
| P478 | volume | 283 |
| Q68807607 | A cytological analysis of FMC-7 positive leukaemias |
| Q40117180 | A monoclonal antibody that blocks class II histocompatibility-related immune interactions |
| Q68793194 | A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes |
| Q41123925 | A novel human monoclonal antibody rapidly induces homotypic cell aggregation and promotes antibody-secreting activity by human B lymphoblastoid cell line IM-9. |
| Q68530877 | A phenotypic study of B lymphocyte subpopulations in human bone marrow |
| Q37025725 | A unique cell surface antigen identifying lymphoid malignancies of B cell origin |
| Q58415262 | AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT |
| Q59194535 | Acid phosphatase and acid esterase activity in neoplastic and non-neoplastic lymphoid cells A semiquantitative evaluation related to immunological markers in 112 cases |
| Q53915117 | Acute leukaemia with mixed lymphoid and myeloid phenotype. |
| Q40201545 | Acute lymphoblastic leukemia in children: current status, controversies, and future perspective |
| Q70232232 | Acute lymphoblastic leukemia polymorphism disclosed by monoclonal antibodies |
| Q41947771 | Adult T Lymphoblastic Leukemia (Pro-T ALL) with Reactive Monocytosis: A Case Report |
| Q36026943 | Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period |
| Q70353900 | Antibodies and cancer therapy |
| Q40112653 | Antibody Mediated Delivery of Toxic Molecules to Antigen Bearing Target Cells |
| Q46766509 | Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cells |
| Q39740848 | Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview |
| Q35180975 | Atypical fibroxanthoma |
| Q68409018 | Autologous antibodies to human bladder cancer |
| Q36992671 | B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation |
| Q37686904 | B-cell monoclonal antibodies and their use in clinical oncology |
| Q69954634 | B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation |
| Q43759152 | Biallelic heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia |
| Q48973397 | Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues |
| Q37191800 | Biphenotypic leukaemia: a case of mixed T lymphoblastic and myeloblastic leukaemia |
| Q36027771 | Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line |
| Q73348296 | CD10 Expression is Useful in the Diagnosis of Follicular Carcinoma and Follicular Variant of Papillary Thyroid Carcinoma |
| Q36365344 | CD2 regulates responsiveness of activated T cells to interleukin 12. |
| Q58415179 | CD2-CD58 Interaction and the Control of T-Cell Interleukin-12 Responsiveness |
| Q82713435 | Can CD10 be used as a diagnostic marker in thyroid pathology? |
| Q40147232 | Cell lineage in lymphoproliferative disease |
| Q39502757 | Cell surface markers in leukemia: biological and clinical correlations |
| Q72379840 | Cellular immunology in the baboon (Papio cynocephalus): examination of structural and functional characteristics of adult and fetal lymphoid cells |
| Q72742862 | Characterization of a Monoclonal Antibody (A12) that Defines a Human Acute Lymphoblastic Leukemia-Associated Differentiation Antigen |
| Q36348858 | Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome |
| Q36046139 | Characterization of a monoclonal antibody to L1210 leukaemia |
| Q44536215 | Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. II. Studies with monoclonal antibodies and terminal transferase |
| Q46466499 | Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg). |
| Q70998800 | Characterization of immune complexes in acute lymphoblastic leukaemia |
| Q52831406 | Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines: Analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry |
| Q68413346 | Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells |
| Q28114929 | Chromosome assignment of monoclonal antibody-defined determinants on human leukemic cells |
| Q58415246 | Clinical Applications of Monoclonal Antibodies in Acute Leukemia |
| Q24303930 | Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis |
| Q34567250 | Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity |
| Q36355516 | Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase |
| Q69857642 | Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia |
| Q47649382 | Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation |
| Q53560573 | Detection of cALLA Positive Cells in the Human Normal Peripheral Blood by Microimmunofluorometry and their Fate during Cultivation in Diffusion Chambers |
| Q69381746 | Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization |
| Q40926805 | Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients |
| Q36380111 | Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells |
| Q40831574 | Developments in purging in autotransplantation. |
| Q36988433 | Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. |
| Q72840388 | Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma |
| Q75209111 | Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology |
| Q33929593 | Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells |
| Q42840692 | Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10) |
| Q37392755 | Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity |
| Q37404033 | Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6. |
| Q72810160 | Distinction between burkitt lymphoma subgroups by monoclonal antibodies: Relationships between antigen expression and type of chromosomal translocation |
| Q70361498 | Distribution of B lymphocyte subsets in normal lymphoid tissue |
| Q36345745 | Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues |
| Q24605501 | Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines |
| Q59063435 | Downregulation of enkephalin-mediated inflammatory responses by CDl0/neutral endopeptidase 24.11 |
| Q72711536 | Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells |
| Q70513383 | Enumeration of cytoplasmic mu immunoglobulin positive acute lymphoblastic leukemia cells by flow cytometry: comparison with fluorescence microscopy |
| Q34366291 | Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells |
| Q45796496 | Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements |
| Q45837923 | Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance |
| Q44931546 | Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes |
| Q35982370 | Establishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line |
| Q33822136 | Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. |
| Q80799472 | Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis |
| Q71535222 | Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon |
| Q55489905 | Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. |
| Q36586321 | Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatment |
| Q37004140 | Expression of myeloid differentiation antigens on normal and malignant myeloid cells |
| Q72647272 | Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy |
| Q37194438 | Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease |
| Q70308634 | Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy |
| Q34535750 | Functional and phenotypic studies of Japanese adult T cell leukemia cells |
| Q42263200 | HNK-1 antibody detects an antigen expressed on neuroectodermal cells |
| Q72438989 | Haemopoietic stem cell autografts for leukaemia |
| Q72555328 | Human Thy-1 antigen: cell surface expression on early T and B lymphocytes |
| Q41697356 | Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage |
| Q52265372 | Human mononuclear phagocyte differentiation: a study of the U-937 cell line by ultrastructural cytochemistry and surface antigen analysis. |
| Q24308489 | Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein |
| Q40105074 | Human tumor-associated antigens identified by monoclonal antibodies |
| Q52830996 | Human-human hybridomas secreting antibodies specific to human lung carcinoma. |
| Q40102095 | Hybridomas: a new dimension in biological analyses |
| Q68132103 | Identification and purification of human erythroid progenitor cells by monoclonal antibody to the transferrin receptor (TU 67) |
| Q34556074 | Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma |
| Q70287204 | Immune complexes and circulating antibodies against autologous leukaemic cells in patients with acute leukaemias |
| Q68502385 | Immunobiology of chronic lymphocytic leukemia |
| Q70299288 | Immunoenzymatic staining of haematological samples with monoclonal antibodies |
| Q70280558 | Immunofluorescence with monoclonal antibodies on poly-L-lysine coated slides: an alternative to conventional methods |
| Q35203032 | Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. |
| Q41856776 | Immunoglobulin negative follicle centre cell lymphoma |
| Q45774798 | Immunohistochemical analysis on normal nephrogenesis and Wilms' tumour using monoclonal antibodies reactive with lymphohaemopoietic antigens |
| Q35858151 | Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entitie |
| Q40199983 | Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. |
| Q35864034 | Immunologic diagnosis and monitoring of human acute leukemias: a review. |
| Q70276602 | Immunological classification of T-cell acute lymphoblastic leukaemia using monoclonal antibodies |
| Q45886971 | Immunological phenotype of neoplasms involving the B cell in the last step of differentiation |
| Q38020369 | Immunophenotyping in haematological diagnosis |
| Q70330769 | Immunophenotyping of leukaemia: an immunoperoxidase method using air-dried smears |
| Q72830647 | Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry |
| Q70196617 | In situ immunocytochemical staining of cell colonies growing in plasma clot |
| Q33394517 | Increase of CALLA-positive stimulated lymphoid cells in transient erythroblastopenia of childhood |
| Q46527369 | Induction of differentiation of African Burkitt's lymphoma cells by phorbol ester: possible relation with early B cells |
| Q37016392 | Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia |
| Q69986623 | Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes |
| Q36480878 | Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo |
| Q24527312 | Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol) |
| Q36363268 | Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells |
| Q39549531 | Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies |
| Q35589245 | Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis |
| Q39649028 | Localisation of CD10 to biliary canaliculi by immunoelectron microscopical examination |
| Q35857873 | Low-grade lymphomas. Expression of developmentally regulated B-cell antigens |
| Q40244509 | Lymphocyte hybridomas |
| Q39825439 | Magnetic separation techniques: their application to medicine. |
| Q46607415 | Malignant rhabdoid tumour of the kidney expressing neurofilament proteins. Immunohistochemical findings and histogenetic aspects |
| Q40101164 | Mapping Cell Surface Antigen Expression of Haemopoietic Progenitor Cells using Monoclonal Antibodies |
| Q39500205 | Membrane antigen expression during hemopoietic differentiation |
| Q39530292 | Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens |
| Q72654309 | Methods for production of monoclonal antibodies with specificity for human lung cancer cells |
| Q24294498 | Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein |
| Q72742884 | Monoclonal Antibodies Directed Against Human Lymphoid, Monocytic, and Granulocytic Cells: Reactivities with Other Tissues |
| Q58415195 | Monoclonal Antibody-Purged Bone Marrow Transplantation Therapy for Multiple Myeloma |
| Q70157431 | Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells |
| Q70450882 | Monoclonal antibodies against differentiation antigens of lymphopoiesis |
| Q40316407 | Monoclonal antibodies and human disease. |
| Q40248951 | Monoclonal antibodies and human tumor pathology |
| Q40289639 | Monoclonal antibodies as tools in hematology |
| Q40155227 | Monoclonal antibodies in clinical medicine--a review |
| Q41933230 | Monoclonal antibodies in diagnosis and treatment |
| Q40201565 | Monoclonal antibodies in the treatment of cancer |
| Q41459137 | Monoclonal antibodies reactive with human myeloid leukaemia cells |
| Q35409906 | Monoclonal antibodies that demonstrate specificity for several types of human lung cancer |
| Q44846277 | Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy |
| Q41509074 | Monoclonal antibodies to human colon and colorectal carcinoma |
| Q70481115 | Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production |
| Q38670749 | Monoclonal antibodies: clinical applications |
| Q36376082 | Monoclonal antibody against a Burkitt lymphoma-associated antigen |
| Q35835090 | Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience |
| Q72516537 | Monoclonal antibody specific for human T acute lymphoblastic leukaemia |
| Q37603317 | Monoclonal antibody that defines a unique human T-cell leukemia antigen |
| Q68876865 | Monoclonal antibody-defined antigens of human prostate cancer cell line PC3 |
| Q72719445 | Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells |
| Q44778335 | Murine Hybridoma Antibodies Against Human Transitional Carcinoma-Associated Antigens |
| Q54329902 | Murine thymocytes possess specific cell surface-associated exoaminopeptidase activities: preferential expression by immature CD4-CD8- subpopulation. |
| Q52833105 | NALL-1, an acute lymphoblastic leukemia cell line with peroxidase activity |
| Q57035429 | Neprilysin levels at the acute phase of ST-elevation myocardial infarction |
| Q36795950 | Neutral endopeptidase modulates septic shock |
| Q36364975 | Neutral endopeptidase modulation of septic shock. |
| Q36531346 | Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways |
| Q34209118 | Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction |
| Q36232379 | Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion |
| Q72662582 | New antigenic determinant common to human thymus leukaemia-associated antigens and common acute lymphoblastic leukaemia antigen |
| Q37188421 | Normal values for the different classes of venous blood mononuclear cells defined by monoclonal antibodies |
| Q36344615 | P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody |
| Q40168284 | Peripheral blood of patients with cutaneous T-cell lymphoma: studies using monoclonal antibodies |
| Q35858079 | Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues |
| Q35835460 | Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues |
| Q41143561 | Phenotypic profile of human neuroblastoma cell lines: association with morphological characteristics |
| Q46881596 | Phylogenetic distribution of a 24,000 dalton human leukemia-associated antigen on platelets and kidney cells |
| Q36347563 | Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen |
| Q41466205 | Present status and future prospects for the hybridoma technology |
| Q41746328 | Production and characterization of a human monoclonal antibody recognizing a new antigen expressed on some lymphoid cells. |
| Q40696870 | Prognostic significance of the surface antigens expressed by leukemic cells. |
| Q41056716 | Purging of autografts: methods and clinical significance |
| Q36347276 | Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). |
| Q44573792 | Quantitation of mu mRNA by in situ hybridization reveals a correlation between B-maturation associated antigens and IgM gene activation in acute lymphatic leukemias |
| Q35208867 | Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts |
| Q37343305 | Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia |
| Q39818170 | Removal of tumour cells from bone marrow: an evaluation of the available techniques |
| Q28077503 | Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis |
| Q35835286 | SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage |
| Q45173925 | Sequential development of distinct clonal chromosome abnormalities in a patient with preleukaemia |
| Q36304706 | Serological analysis of cell surface antigens of null cell acute lymphocytic leukemia by mouse monoclonal antibodies |
| Q41506848 | Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody |
| Q43810202 | Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission |
| Q38355325 | Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9 |
| Q38655812 | Structure, function, and genetics of human B cell-associated surface molecules |
| Q72831743 | Suppressor T cell chronic lymphocytic leukaemia associated with red cell hypoplasia |
| Q53533810 | Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. |
| Q46911712 | Symposium: classification of leukemia* 1. the classification of acute leukemia |
| Q35577532 | T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia |
| Q40167085 | Targeting potential of antibody conjugates |
| Q68801966 | Telomeric fusion in pre-T-cell acute lymphoblastic leukemia |
| Q44763753 | Terminal deoxynucleotidyl transferase and HLA-DR expression appear unrelated to prognosis of acute myeloid leukaemia |
| Q42840126 | Terminal transferase positive cells in testicular biopsy specimens from boys with acute lymphoblastic leukaemia |
| Q36828608 | The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation |
| Q36047539 | The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques |
| Q70190440 | The childhood leukemias |
| Q70276606 | The demonstration of terminal deoxynucleotidyl transferase on frozen tissue sections and smears by the avidin-biotin complex (ABC) method |
| Q41365651 | The distribution of CD10 (NEP 24.11, CALLA) in humans and mice is similar in non-lymphoid organs but differs within the hematopoietic system: absence on murine T and B lymphoid progenitors |
| Q39343410 | The impact of future technology on oncologic diagnosis: Oncologic imaging and diagnosis |
| Q68727539 | The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia |
| Q89732159 | The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins |
| Q50900303 | The purification of human basophils: their immunophenotype and cytochemistry |
| Q37586041 | The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited |
| Q41885625 | Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells |
| Q69866291 | Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles |
| Q43540239 | Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases. |
| Q40162882 | Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation |
| Q70924024 | Utilization of monoclonal antibodies and immuno-scanning electron microscopy for the positive identification of human leukemic cells |
| Q72710284 | VIL-A1, A monoclonal antibody reactive with common acute lymphatic leukemia cells |
| Q86413963 | Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma |
| Q44345035 | Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host |
| Q72688754 | [Chemotherapy of tumors] |
| Q35746882 | cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. |
Search more.